Literature DB >> 16028385

[Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].

K Iamakov, B Pekhlivanov, I Amaliev.   

Abstract

UNLABELLED: Medical abortion means interruption of early pregnancy (usually before 9-th gestational week) as a result of administration of abortifacient drugs without surgical intervention.
OBJECTIVE: To investigate the efficacy and tolerability of methotrexate plus misoprostol regimen as a method for early medical abortion < 49 days L.M.P. MATERIAL AND
METHOD: 50 mg methotrexate was administered orally to 20 women < 49 days L.M.P. followed by 800 mcg misoprostol vaginal and oral administration 3-7 days after the methotrexate.
RESULTS: 19 Successful medical abortions (95%). One woman chose vacuum aspiration for termination of the abortion on day 3 of the induced bleeding. No serious side effects were observed after administration of the drugs.
CONCLUSION: Medical abortion with methotrexate and misoprostol is safe and effective and can be offered to practicing gynecologists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16028385

Source DB:  PubMed          Journal:  Akush Ginekol (Sofiia)        ISSN: 0324-0959


  2 in total

1.  Formulation and in vitro characterization of xanthan gum-based sustained release matrix tables of isosorbide-5- mononitrate.

Authors:  Rajat Kar; Snehamayee Mohapatra; Satyabrata Bhanja; Debjyoti Das; Bhaktibhusan Barik
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

2.  Misoprostol alone or in combination with methotrexate for termination of pregnancy at first trimester.

Authors:  Fatemeh Vahid Roudsari; Sedigheh Ayati; Nafiseh Saghafy; Mohamadtaghi Shakeri
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.